TMCI:NASDAQ
Treace Medical Concepts, Inc
4,44 $
arrow_upward
+1,14%(+0,050) 1D
5 հոկ, 13:09:49 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TMCI...
Open
4,40 $
High
4,48 $
Low
4,24 $
Mkt. cap
288,75 մլն
Avg. vol.
238,13 հզր
Volume
68,84 հզր
52-wk high
7,08 $
52-wk low
1,17 $
EPS
-0,93 $
Beta
1,48
Shares outstanding
65,04 մլն
No. of employees
450
Open
4,40 $
High
4,48 $
Low
4,24 $
Mkt. cap
288,75 մլն
Avg. vol.
238,13 հզր
Volume
68,84 հզր
52-wk high
7,08 $
52-wk low
1,17 $
EPS
-0,93 $
Beta
1,48
Shares outstanding
65,04 մլն
No. of employees
450
News stories
From web sources and news partners
sUAS News
·
15 րոպե առաջ
Powerus (Nasdaq: PUSA) Awarded $82 Million Order for Counter-Unmanned Aerial Systems
Simply Wall Street
·
9 րոպե առաջ
October 2026's Trio Of Stocks Possibly Priced Below Estimated Value
Quiver Quantitative
·
9 րոպե առաջ
SCWorx Corp. Regains Nasdaq Listing Compliance as Panel Approves Continued Listing and Trading Reinstatement
Seeking Alpha
·
52 րոպե առաջ
S&P 500 nears record high despite the struggling underlining breadth
Profile
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
About Treace Medical Concepts, Inc